State of Wyoming Boosts Holdings in Axon Enterprise, Inc $AXON

State of Wyoming boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 426.9% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,333 shares of the biotechnology company’s stock after purchasing an additional 1,080 shares during the period. State of Wyoming’s holdings in Axon Enterprise were worth $747,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. ABN AMRO Bank N.V. raised its holdings in Axon Enterprise by 107.7% in the second quarter. ABN AMRO Bank N.V. now owns 1,080 shares of the biotechnology company’s stock worth $604,000 after buying an additional 560 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Axon Enterprise by 38.3% during the second quarter. Russell Investments Group Ltd. now owns 145,209 shares of the biotechnology company’s stock valued at $79,947,000 after acquiring an additional 40,214 shares in the last quarter. WPG Advisers LLC increased its position in shares of Axon Enterprise by 108.5% during the second quarter. WPG Advisers LLC now owns 269 shares of the biotechnology company’s stock valued at $151,000 after acquiring an additional 140 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp increased its position in shares of Axon Enterprise by 6.0% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 93,914 shares of the biotechnology company’s stock valued at $52,649,000 after acquiring an additional 5,300 shares in the last quarter. Finally, Meridian Wealth Management LLC raised its holdings in Axon Enterprise by 24.5% in the 2nd quarter. Meridian Wealth Management LLC now owns 971 shares of the biotechnology company’s stock worth $544,000 after acquiring an additional 191 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported quarterly earnings of $1.88 per share, exceeding the $1.84 consensus estimate, while revenue reached $904.4 million versus expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the growth outlook for its public-safety technology, connected devices and software businesses. Axon Enterprise stock in focus after strong quarter
• Positive Sentiment: A Motley Fool article highlighted Axon as a category leader that continues to deliver double-digit revenue growth despite trading below its prior high, supporting the case for long-term investors willing to hold the stock for a decade. Two stocks to buy and hold for the next decade
• Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for the first three quarters of 2027. The firm also lifted its Q3 2026 estimate to $1.01 from $0.85, signaling stronger anticipated earnings momentum beyond the current year.
• Neutral Sentiment: Northland’s revisions were mixed: it reduced its FY2026 EPS forecast to $3.12 from $3.26 and lowered Q4 2026 expectations to $1.29 from $1.55, while raising several 2027 forecasts. This suggests near-term execution concerns but improved longer-term expectations.
• Negative Sentiment: AXON’s valuation remains demanding, with a reported price-to-earnings ratio above 250 and a PEG ratio near 10. Strong growth is already reflected in the share price, leaving the stock vulnerable to profit-taking or disappointment if future results do not exceed elevated expectations.

Analyst Ratings Changes

Several research firms recently issued reports on AXON. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a research report on Thursday, June 25th. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Morgan Stanley boosted their price target on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. upped their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Finally, Barclays increased their price objective on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $730.92.

Insider Activity

In related news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the sale, the insider owned 52,813 shares of the company’s stock, valued at $21,125,200. The trade was a 3.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the sale, the insider owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 68,989 shares of company stock worth $36,016,932. Insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $612.83 on Monday. The company has a market cap of $49.79 billion, a price-to-earnings ratio of 254.29, a price-to-earnings-growth ratio of 9.95 and a beta of 1.39. The company’s 50 day moving average is $526.06 and its 200 day moving average is $473.48. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $794.29. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter last year, the company posted $2.12 earnings per share. The firm’s quarterly revenue was up 35.3% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.